SVNS — Solvonis Therapeutics Share News
0.000.00%
- £17.36m
- £15.72m
- 21
- 12
- 59
- 18
REG - Solvonis Therapeutic - Holding(s) in Company
AnnouncementREG - Solvonis Therapeutic - Engagement of PharmaVentures
AnnouncementREG - Solvonis Therapeutic - Positive progress on European Patent Application
AnnouncementREG - Solvonis Therapeutic - Update on AWKN-SDN-14 programme
AnnouncementREG - Solvonis Therapeutic - Holding(s) in Company
AnnouncementREG - Solvonis Therapeutic - Appointment of Non-Executive Director
AnnouncementRCS - Solvonis Therapeutic - Presentation at PharmaSynergyRx Event
AnnouncementREG - Solvonis Therapeutic - Entry into an Arrangement Agreement with Awakn
AnnouncementRCS - Solvonis Therapeutic - Proactive Investors interview with Chairman
AnnouncementREG - Solvonis Therapeutic - Update on Awakn Life Sciences’ R&D Progress
AnnouncementRCS - Solvonis Therapeutic - Investor Presentation
AnnouncementRCS - Solvonis Therapeutic - Proactive Investors interview with CEO
AnnouncementREG - Solvonis Therapeutic - Update on FDA Pre-IND Meeting for Awakn
Announcement